376 related articles for article (PubMed ID: 36192502)
1. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
[TBL] [Abstract][Full Text] [Related]
2. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.
Zhou L; Luo Y; Liu Y; Zeng Y; Tong J; Li M; Hou Y; Du K; Qi Y; Pan W; Liu Y; Wang R; Tian F; Gu C; Chen K
Cancer Res; 2023 Dec; 83(23):3920-3939. PubMed ID: 37729394
[TBL] [Abstract][Full Text] [Related]
4. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
5. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
6. Lipid in Renal Carcinoma: Queen Bee to Target?
Tan SK; Welford SM
Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
[TBL] [Abstract][Full Text] [Related]
8. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
[TBL] [Abstract][Full Text] [Related]
9. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming of clear cell renal cell carcinoma.
Zhu H; Wang X; Lu S; Ou K
Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
[TBL] [Abstract][Full Text] [Related]
13. Targeting lipid metabolism in the treatment of ovarian cancer.
Chaudhry S; Thomas SN; Simmons GE
Oncotarget; 2022; 13():768-783. PubMed ID: 35634242
[TBL] [Abstract][Full Text] [Related]
14. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
15. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract][Full Text] [Related]
16. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
[TBL] [Abstract][Full Text] [Related]
17. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
[TBL] [Abstract][Full Text] [Related]
18. Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED; Kimbrough EO; Vemireddy LP; Surapaneni PK; Copland JA; Mody K
Expert Opin Ther Targets; 2019 Jun; 23(6):473-483. PubMed ID: 31076001
[TBL] [Abstract][Full Text] [Related]
19. Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes.
Shinohara S; Gu Y; Yang Y; Furuta Y; Tanaka M; Yue X; Wang W; Kitano M; Kimura H
Int J Mol Med; 2016 Aug; 38(2):574-84. PubMed ID: 27353085
[TBL] [Abstract][Full Text] [Related]
20. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
